scholarly journals Signaling pathways in breast cancer metastasis - novel insights from functional genomics

2011 ◽  
Vol 13 (2) ◽  
Author(s):  
Mario Andres Blanco ◽  
Yibin Kang
2011 ◽  
Author(s):  
Kyle R. Covington ◽  
Lauren Brusco ◽  
Amanda Beyer ◽  
Weiyan Cai ◽  
Arnoldo Corona-Rodriguez ◽  
...  

2013 ◽  
Author(s):  
Ming Gene Chai ◽  
Caroline P. Le ◽  
Sarah J. Creed ◽  
Benjamin A L Finnin ◽  
Matthew A. Pimentel ◽  
...  

2011 ◽  
Vol 22 (8) ◽  
pp. 732-740 ◽  
Author(s):  
Pei-Hsuan Chen ◽  
Chieh-Yu Peng ◽  
Hui-Chen Pai ◽  
Che-Ming Teng ◽  
Chien-Chih Chen ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (30) ◽  
pp. 48889-48904 ◽  
Author(s):  
Kaili Lian ◽  
Chao Ma ◽  
Chunyan Hao ◽  
Yan Li ◽  
Na Zhang ◽  
...  

Author(s):  
Shivashankar Pranavkrishna ◽  
Ganesh Sanjeev ◽  
Ravishkumar L. Akshaya ◽  
Muthukumar Rohini ◽  
Nagarajan Selvamurugan

: Posing as a major threat among women globally, breast cancer (BC) emerges as a primary research focus for several researchers. Although various therapeutic regimens are available, there is an increased chance of metastasis of BC cells, which raises the severity of this malignancy. Of multiple preferred secondary targets, metastasis to bone is extensively studied. Besides deemed as a bone transcription factor, Runx2 also acts as a metastatic factor that promotes growth and metastasis of BC cells. Studies have reported the significant role of microRNAs (miRNAs) in BC pathogenesis and metastasis by governing Runx2 expression. Additionally, dysregulation of the signaling pathways, including Wnt/β-catenin, TGF-β, Notch, and PI3K/AKT, have been observed to influence the expression of Runx2 in BC cells. In this review, we have aimed to highlight the regulatory role of miRNAs in targeting Runx2 both directly and indirectly by governing respective signaling pathways during bone metastasis of BC.


Sign in / Sign up

Export Citation Format

Share Document